Abstract
Biodistribution of nonviral cationic vector/DNA complexes was studied after systemic or intratracheal administration to the lungs and correlated with transgene expression. Intravenous injection in C57Bl/6 mice gave maximal and significant luciferase expression in the lungs with the cationic polymer PEI 22K/DNA complexes at the highest ratios of positive/negative charges versus DNA alone. While DOTAP/DNA complexes with high charge ratio determined lower but still significant luciferase activity versus uncomplexed DNA, GL-67A and PEI 25K mediated negligible luciferase expression. Labelled PEI 22K and DOTAP complexes were evenly distributed in the alveolar region, where GFP expression was revealed, while PEI 25K and GL-67A complexes were not detected, suggesting a different interaction of these complexes with the plasma membrane of endothelial cells. Following an intratracheal injection, the highest and significant levels of transfection were obtained with slightly positive PEI complexes as compared with DNA alone, whereas cationic lipid-based vectors, DOTAP and GL-67A, gave not significant luciferase activity. Both types of polyplexes gave similar levels of lung luciferase expression by targeting different airway cell populations. PEI 25K complexes determined high levels of GFP in the bronchial cells, confirming confocal data on fluorescent complexes internalization. PEI 22K complexes gave mainly high GFP signal in the distal tract of the bronchial tree, where tagged complexes were recovered. Fluorescent lipid complexes were found in aggregates in the lumen of bronchi totally (DOTAP) or partially (GL-67A) co-localizing with surfactant protein A. Results indicated that cationic polymers could overcome the surfactant barrier which inhibited airway cell transfection mediated by cationic lipids.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Geddes D, Alton EWFW . Cystic fibrosis clinical trials. In: Kabanov AV, Felgner PL, Seymour LW (eds) Self-Assembling Complexes for Gene Delivery. From Laboratory to Clinical Trial John Wiley: Chichester 1998 pp 403–420
Boucher RC . Status of gene therapy for cystic fibrosis lung disease J Clin Invest 1999 103: 441–445
Alton EWFW et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial Lancet 1999 353: 947–954
Zuckerman JB et al. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis Hum Gene Ther 1999 10: 2973–2985
Oudrhiri N et al. Gene transfer by guanidium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo Proc Natl Acad Sci USA 1997 94: 1651–1656
Ferrari S et al. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo Gene Therapy 1997 4: 1100–1106
Griesenbach U et al. Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapy Gene Therapy 1998 5: 181–188
Eastman SJ et al. Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes Hum Gene Ther 1997 8: 313–322
Eastman SJ et al. A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung Hum Gene Ther 1997 8: 765–773
Templeton NS et al. Improved DNA:liposome complexes for increased systemic delivery and gene expression Nat Biotechnol 1997 15: 647–652
Liu Y et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery Nat Biotechnol 1997 15: 167–173
Goula D et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung Gene Therapy 1998 5: 1291–1295
Bragonzi A et al. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs Gene Therapy 1999 6: 1995–2004
Song YK, Liu F, Chu S, Liu D . Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration Hum Gene Ther 1997 8: 1585–1594
Liu F, Qi H, Huang L, Liu D . Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration Gene Therapy 1997 4: 517–523
Li S, Huang L . In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes Gene Therapy 1997 4: 891–900
Tsan M-F, White JE, Sheppard B . Lung-specific direct in vivo gene transfer with recombinant plasmid DNA Am J Physiol 1995 268: L1052–L1056
Tsan M-F, Tsan GL, White JE . Surfactant inhibits cationic liposome-mediated gene transfer Hum Gene Ther 1997 8: 817–825
Ernst N et al. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant J Gene Med 1999 1: 331–340
Nogee LM et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds J Clin Invest 1994 93: 1860–1863
Mahato RI et al. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration Hum Gene Ther 1998 9: 2083–2099
Yang J-P, Huang L . Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA Gene Therapy 1997 4: 950–960
Li S et al. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection Gene Therapy 1999 6: 585–594
Dunlop DD, Maggi A, Soria MR, Monaco L . Nanoscopic structure of DNA condensed for gene delivery Nucleic Acids Res 1997 25: 3095–3101
Foglieni C et al. Glomerular filtration is required for transfection of proximal tubular cells in the rat kidney following injection of DNA complexes into the renal artery Gene Therapy 2000 7: 279–285
Goula D et al. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes Gene Therapy 2000 7: 499–504
Goula D et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system Gene Therapy 1998 5: 712–717
Chadwick SL et al. Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers Gene Therapy 1997 4: 937–942
Jobe AH et al. Surfactant enhances adenovirus-mediated gene expression in rabbit lungs Gene Therapy 1996 3: 775–779
Korst RJ, Bewig B, Crystal RG . In vitro and in vivo transfer and expression of human surfactant SP-A- and SP-B-associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors Hum Gene Ther 1995 6: 277–287
Thurston G et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice J Clin Invest 1998 101: 1401–1413
Johnson L et al. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis Nat Genet 1992 2: 21–25
Meyer KB et al. Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics Gene Therapy 1995 2: 450–460
Zabner J et al. Comparison of DNA–lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo J Clin Invest 1997 100: 1529–1537
Sambrook J, Fritsch EF, Maniatis T . Molecular Cloning. A Laboratory Manual Cold Spring Harbor Laboratory Press: New York 1989
Neave HR, Worthington PL . Distribution-Free Tests Rontledge: London 1988
Acknowledgements
This study was supported by a grant for cystic fibrosis from the Italian Ministero della Sanità (L548/93) and the Associazione Lombarda Fibrosi Cistica. G Dina was supported by Giovanni Armenise-Harvard Foundation. We would like to thank SH Cheng for providing us with the GL-67A vector.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bragonzi, A., Dina, G., Villa, A. et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 7, 1753–1760 (2000). https://doi.org/10.1038/sj.gt.3301282
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301282
Keywords
This article is cited by
-
Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery
Pharmaceutical Research (2023)
-
Gene therapy: light is finally in the tunnel
Protein & Cell (2011)
-
WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth
Cancer Gene Therapy (2009)
-
Intratracheal Gene Transfer of Adrenomedullin Using Polyplex Nanomicelles Attenuates Monocrotaline-induced Pulmonary Hypertension in Rats
Molecular Therapy (2009)
-
Breaking the Bonds: Non-viral Vectors Become Chemically Dynamic
Molecular Therapy (2008)